Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2017, Article ID 8165458, 2 pages
https://doi.org/10.1155/2017/8165458
Editorial

NRF2 as an Emerging Therapeutic Target

1MRC Centre for Drug Safety Science, Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool L69 3GE, UK
2Division of Cancer Research, School of Medicine, University of Dundee, Dundee DD1 9SY, UK
3Department of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, PA 15261, USA
4Department of Pharmacology and Toxicology, Michigan State University, East Lansing, MI 48824, USA
5Reata Pharmaceuticals Inc., 2801 Gateway Drive, Irving, TX 75063, USA

Correspondence should be addressed to Ian M. Copple; ku.ca.looprevil@elppoci

Received 21 December 2016; Accepted 22 December 2016; Published 31 January 2017

Copyright © 2017 Ian M. Copple et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. L. Clarke, J. B. Murray, B. K. Park, and I. M. Copple, “Roles of Nrf2 in drug and chemical toxicity,” Current Opinion in Toxicology, vol. 1, pp. 104–110, 2016. View at Publisher · View at Google Scholar
  2. T. Suzuki, H. Motohashi, and M. Yamamoto, “Toward clinical application of the Keap1-Nrf2 pathway,” Trends in Pharmacological Sciences, vol. 34, no. 6, pp. 340–346, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. P. Albrecht, I. Bouchachia, N. Goebels et al., “Effects of dimethyl fumarate on neuroprotection and immunomodulation,” Journal of Neuroinflammation, vol. 9, article 163, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. D. Luchtman, R. Gollan, E. Ellwardt et al., “In vivo and in vitro effects of multiple sclerosis immunomodulatory therapeutics on glutamatergic excitotoxicity,” Journal of Neurochemistry, vol. 136, no. 5, pp. 971–980, 2016. View at Publisher · View at Google Scholar · View at Scopus
  5. Z. Zhao, Y. Chen, J. Wang et al., “Age-related retinopathy in NRF2-deficient mice,” PLoS ONE, vol. 6, no. 4, Article ID e19456, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. G. Wells, “Peptide and small molecule inhibitors of the Keap1-Nrf2 protein-protein interaction,” Biochemical Society Transactions, vol. 43, pp. 674–679, 2015. View at Publisher · View at Google Scholar · View at Scopus